520 related articles for article (PubMed ID: 9164874)
1. Molecular cloning and expression of the Candida albicans TOP2 gene allows study of fungal DNA topoisomerase II inhibitors in yeast.
Keller BA; Patel S; Fisher LM
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):329-39. PubMed ID: 9164874
[TBL] [Abstract][Full Text] [Related]
2. The top2-5 mutant of yeast topoisomerase II encodes an enzyme resistant to etoposide and amsacrine.
Jannatipour M; Liu YX; Nitiss JL
J Biol Chem; 1993 Sep; 268(25):18586-92. PubMed ID: 8395511
[TBL] [Abstract][Full Text] [Related]
3. Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine.
Wasserman RA; Wang JC
Cancer Res; 1994 Apr; 54(7):1795-800. PubMed ID: 8137294
[TBL] [Abstract][Full Text] [Related]
4. Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2 beta construct allows the study of topoisomerase II beta inhibitors in yeast.
Meczes EL; Marsh KL; Fisher LM; Rogers MP; Austin CA
Cancer Chemother Pharmacol; 1997; 39(4):367-75. PubMed ID: 9025779
[TBL] [Abstract][Full Text] [Related]
5. Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase II beta.
Austin CA; Marsh KL; Wasserman RA; Willmore E; Sayer PJ; Wang JC; Fisher LM
J Biol Chem; 1995 Jun; 270(26):15739-46. PubMed ID: 7797575
[TBL] [Abstract][Full Text] [Related]
6. Identification of the gene encoding DNA topoisomerase I from Candida albicans.
Taylor A; Giles K; Sarthy AV; McGonigal T; Fostel J
FEMS Microbiol Lett; 1996 May; 138(2-3):113-21. PubMed ID: 9026437
[TBL] [Abstract][Full Text] [Related]
7. Yeast topoisomerase II mutants resistant to anti-topoisomerase agents: identification and characterization of new yeast topoisomerase II mutants selected for resistance to etoposide.
Liu YX; Hsiung Y; Jannatipour M; Yeh Y; Nitiss JL
Cancer Res; 1994 Jun; 54(11):2943-51. PubMed ID: 8187080
[TBL] [Abstract][Full Text] [Related]
8. Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast.
Wasserman RA; Austin CA; Fisher LM; Wang JC
Cancer Res; 1993 Aug; 53(15):3591-6. PubMed ID: 8393377
[TBL] [Abstract][Full Text] [Related]
9. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
[TBL] [Abstract][Full Text] [Related]
10. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
[TBL] [Abstract][Full Text] [Related]
11. Comparison of myristoyl-CoA:protein N-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans.
Lodge JK; Johnson RL; Weinberg RA; Gordon JI
J Biol Chem; 1994 Jan; 269(4):2996-3009. PubMed ID: 8300631
[TBL] [Abstract][Full Text] [Related]
12. Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II.
Nitiss JL; Liu YX; Harbury P; Jannatipour M; Wasserman R; Wang JC
Cancer Res; 1992 Aug; 52(16):4467-72. PubMed ID: 1322791
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and genetic mapping of the DNA topoisomerase II gene of Saccharomyces cerevisiae.
Voelkel-Meiman K; DiNardo S; Sternglanz R
Gene; 1986; 42(2):193-9. PubMed ID: 3015732
[TBL] [Abstract][Full Text] [Related]
14. Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and beta.
Turnbull RM; Meczes EL; Perenna Rogers M; Lock RB; Sullivan DM; Finlay GJ; Baguley BC; Austin CA
Cancer Chemother Pharmacol; 1999; 44(4):275-82. PubMed ID: 10447574
[TBL] [Abstract][Full Text] [Related]
15. Identification of yeast DNA topoisomerase II mutants resistant to the antitumor drug doxorubicin: implications for the mechanisms of doxorubicin action and cytotoxicity.
Patel S; Sprung AU; Keller BA; Heaton VJ; Fisher LM
Mol Pharmacol; 1997 Oct; 52(4):658-66. PubMed ID: 9380029
[TBL] [Abstract][Full Text] [Related]
16. The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II.
Caron PR; Watt P; Wang JC
Mol Cell Biol; 1994 May; 14(5):3197-207. PubMed ID: 8164675
[TBL] [Abstract][Full Text] [Related]
17. Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II.
Goto T; Wang JC
Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7178-82. PubMed ID: 2997777
[TBL] [Abstract][Full Text] [Related]
18. The ARO4 gene of Candida albicans encodes a tyrosine-sensitive DAHP synthase: evolution, functional conservation and phenotype of Aro3p-, Aro4p-deficient mutants.
Sousa S; McLaughlin MM; Pereira SA; VanHorn S; Knowlton R; Brown JR; Nicholas RO; Livi GP
Microbiology (Reading); 2002 May; 148(Pt 5):1291-1303. PubMed ID: 11988503
[TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae.
Ishida R; Hamatake M; Wasserman RA; Nitiss JL; Wang JC; Andoh T
Cancer Res; 1995 Jun; 55(11):2299-303. PubMed ID: 7757979
[TBL] [Abstract][Full Text] [Related]
20. Genetic characterization of a phospholipase C gene from Candida albicans: presence of homologous sequences in Candida species other than Candida albicans.
Bennett DE; McCreary CE; Coleman DC
Microbiology (Reading); 1998 Jan; 144 ( Pt 1)():55-72. PubMed ID: 9467900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
